Stock 301335 HANGZHOU TIANYUAN PET PRODUCTS CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Hangzhou Tianyuan Pet Products CO., LTD

Equities

301335

CNE1000065H8

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-06-18 EDT 		5-day change 1st Jan Change
16.15 CNY -0.25% Intraday chart for Hangzhou Tianyuan Pet Products CO., LTD -5.56% -24.53%
06-11 Hangzhou Tianyuan Pet Products Co., Ltd Implements Final Profit Distribution Plan of A Shares for 2023, Payable on 18 June 2024 CI
05-20 Tranche Update on Hangzhou Tianyuan Pet Products CO., LTD's Equity Buyback Plan announced on February 20, 2024. CI

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • The company appears to be poorly valued given its net asset value.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company does not generate enough profits, which is an alarming weak point.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Sector: Other Specialty Retailers

1st Jan change Capi. Investor Rating ESG Refinitiv
HANGZHOU TIANYUAN PET PRODUCTS CO., LTD Stock Hangzhou Tianyuan Pet Products CO., LTD
-24.53% 277M -
CHEWY, INC. Stock Chewy, Inc.
+9.90% 11.32B
D+
ZOOPLUS SE Stock zooplus SE
+7.41% 1.78B -
C+
PETS AT HOME GROUP PLC Stock Pets at Home Group Plc
-5.85% 1.77B
B+
PET VALU HOLDINGS LTD. Stock Pet Valu Holdings Ltd.
-8.62% 1.37B -
PETCO HEALTH AND WELLNESS COMPANY, INC. Stock Petco Health and Wellness Company, Inc.
+15.51% 996M
C+
MUSTI GROUP OYJ Stock Musti Group Oyj
-1.61% 923M
B
BARK, INC. Stock BARK, Inc.
+76.29% 249M -
WONDER PETS ENTERPRISES CORPORATION Stock Wonder Pets Enterprises Corporation
+1.31% 105M - -
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
-
  1. Stock Market
  2. Equities
  3. 301335 Stock
  4. Ratings Hangzhou Tianyuan Pet Products CO., LTD